Bausch Health Companies Inc. 8-K

What Happened

• Bausch Health Companies Inc. (Bausch Health) filed a Form 8-K reporting it will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with the presentation expected at approximately 3:45 p.m. PT (6:45 p.m. ET). Management will provide strategic and business updates and expects to reaffirm its full-year 2025 guidance at the higher end of the range for "Bausch Health excluding Bausch + Lomb Corporation" as previously provided in the company’s Q3 2025 press release dated October 29, 2025. A live audio webcast, replay and presentation materials will be available on the company’s Investor Relations website.

Key Details

• Event: 44th Annual J.P. Morgan Healthcare Conference, Jan 14, 2026; presentation ~3:45 p.m. PT (6:45 p.m. ET).
• Guidance: Management expects to reaffirm full-year 2025 guidance at the higher end of the previously disclosed range for Bausch Health excluding Bausch + Lomb.
• Disclosure items: Form 8‑K reports Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Forward-looking statements: The filing includes a cautionary note that presentation materials may contain forward-looking statements and that the company does not intend to update them except as required by law.

Why It Matters

• The presentation and reaffirmed guidance give investors an updated view of Bausch Health’s strategic priorities and expected financial performance for 2025 (excluding Bausch + Lomb), which can influence sentiment around the company’s revenue and earnings outlook. The Regulation FD disclosure and forward-looking statement caution remind investors to consider the company’s risk factors and prior SEC/Canadian filings when evaluating guidance and projections.